Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: A possible association with oral midodrine treatment

Movement Disorders

Volumn 22, Issue 7, 2007, Pages 1043-1046

  Kim, Joong Seok ^a   Lee, Kwang Soo ^a,c   Lim, Sung Chul ^a   Ahn, Jae Young ^a   Song, In Uk ^a   Kim, Yeong In ^a   Kim, Bum Soo ^a   Kim, Hee Tae ^b  

^a The Catholic University of Korea   (South Korea)

^b Hanyang University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Midodrine; Multiple system atrophy; Orthostatic hypotension; Reversible posterior leukoencephalopathy syndrome

Indexed keywords

LEVODOPA; MIDODRINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DYSARTHRIA; HEADACHE; HUMAN; HYPERTENSION; IMAGE ANALYSIS; LEUKOENCEPHALOPATHY; MALE; ORTHOSTATIC HYPOTENSION; PRESCRIPTION; PRIORITY JOURNAL; REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; RISK FACTOR; SHY DRAGER SYNDROME; SYMPTOM; TONIC CLONIC SEIZURE;

ADRENERGIC ALPHA-AGONISTS; BRAIN; DEMENTIA, VASCULAR; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIDODRINE; MULTIPLE SYSTEM ATROPHY;

EID: 34347249931     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21461     Document Type: Article

References (16)

1. Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med 2001;77:24-28.
2. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
3. de Seze J, Mastain B, Stojkovic T, et al. Unusual MR findings of the brain stem in arterial hypertension. Am J Neuroradiol 2000; 21:391-394.
4. Cruz-Flores S, de Assis Aquino Gondim F, Leira EC. Brainstem involvement in hypertensive encephalopathy: clinical and radiological findings. Neurology 2004;62:1417-1419.
5. Kitaguchi H, Tomimoto H, Miki Y, et al. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 2005;47:652-656.
6. Mauro VF. Focus on midodrine: an oral peripheral-acting α-agonist for the treatment of orthostatic hypotension. Formulary 1997; 32:225-231.
7. Robertson D, Davis TL. Recent advances in the treatment of orthostatic hypotension. Neurology 1995;45:S26-S32.
8. McClellan KJ, Wiseman LR, Wilde MI. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension. Drugs Aging 1998;12:76-86.
9. Johansson B. Regional cerebral blood flow in acute experimental hypertension. Acta Neurol Scand 1974;50:366-372.
10. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379-383.
11. Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28:1082-1085.
12. Trommer BL, Honer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326-329.
13. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension. Neurology 1998;51: 1369-1376.
14. Chu K, Kang DW, Lee SH, Kim M. Diffusion-weighted MR findings in brain stem hypertensive encephalopathy: a possibility of cytotoxic edema? Eur Neurol 2001;46:220-222.
15. Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging 2006;16:170-175.
16. Giner V, Fernandez C, Esteban MJ, et al. Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report. Am J Hypertens 2002;15:465-467.